{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:59:23Z","timestamp":1792501163432,"version":"4.5.0"},"reference-count":25,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,4,29]],"date-time":"2010-04-29T00:00:00Z","timestamp":1272499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:sec><jats:label\/><jats:p> <jats:italic>Aliment Pharmacol Ther<\/jats:italic> 2010; <jats:bold>32:<\/jats:bold> 182\u2013190<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Nighttime heartburn, common among patients with gastro\u2010oesophageal reflux disease (GERD), is associated with substantial clinical effects. GERD\u2010related sleep disturbances are underappreciated and undertreated.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To evaluate the efficacy of esomeprazole on GERD\u2010related nighttime heartburn and associated sleep disturbances.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> In this multicentre, randomized, double\u2010blind, placebo\u2010controlled study, patients with moderate\u2010to\u2010severe nighttime heartburn and GERD\u2010related sleep disturbances (endoscopies not required) received esomeprazole 20\u2003mg or placebo each morning for 4\u2003weeks. Heartburn symptoms and GERD\u2010related sleep disturbances were evaluated using the validated Pittsburgh Sleep Quality Index and validated Work Productivity and Activity Impairment Questionnaire.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> The analysis included 262 patients (esomeprazole, <jats:italic>n<\/jats:italic>\u2003=\u2003137; placebo, <jats:italic>n<\/jats:italic>\u2003=\u2003125). Significantly more patients receiving esomeprazole achieved nighttime heartburn relief (primary end point) than those receiving placebo (34.3% vs. 10.4%; <jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.0001). Secondary end points such as relief of GERD\u2010related sleep disturbances (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0.006), days without GERD\u2010related sleep disturbances (<jats:italic>P\u2003<\/jats:italic>= 0.0003) and complete resolution of sleep disturbances (<jats:italic>P\u2003<\/jats:italic>&lt;<jats:italic>\u2003<\/jats:italic>0.0001) favoured esomeprazole over placebo. Sleep quality, work productivity and regular daily activities also improved significantly with esomeprazole vs. placebo.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Esomeprazole 20\u2003mg is effective for patients with moderate\u2010to\u2010severe nighttime heartburn and GERD\u2010related sleep disturbances, improving heartburn symptoms, sleep quality, work productivity and functionality.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-2036.2010.04339.x","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T10:10:46Z","timestamp":1272622246000},"page":"182-190","source":"Crossref","is-referenced-by-count":38,"title":["Clinical trial: esomeprazole for moderate\u2010to\u2010severe nighttime heartburn and gastro\u2010oesophageal reflux disease\u2010related sleep disturbances"],"prefix":"10.1111","volume":"32","author":[{"given":"D.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.1.45"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07531.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03189.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.04.005"},{"key":"e_1_2_6_6_2","first-page":"589","article-title":"Prevalence of sleep disturbances among young adults in three European countries","volume":"18","author":"Janson C","year":"1995","journal-title":"Sleep"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4733.2002.52101.x"},{"key":"e_1_2_6_8_2","first-page":"6","article-title":"The cost of gastroesophageal reflux disease: it\u2019s what you don\u2019t see that counts","volume":"7","author":"Dean BB","year":"2003","journal-title":"J Manag Care Med"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb03901.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903183401101"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000080309"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02239.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31802fc1bc"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03671.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00285.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02310.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02213.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02573.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01770.x"},{"key":"e_1_2_6_20_2","first-page":"1649","article-title":"The effect of acid suppression on sleep and cardiac autonomic regulation in GERD","volume":"55","author":"Yi CH","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_6_21_2","unstructured":"AstraZeneca LP.Nexium [prescribing information]. Wilmington DE:AstraZeneca LP 2008."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-199304050-00006"},{"key":"e_1_2_6_24_2","unstructured":"Bureau of Labor Statistics.Employer costs for employee compensation news release. Available at:http:\/\/www.bls.gov\/news.release\/ecec.htm. Accessed June 2008."},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178669"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04064.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2010.04339.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2010.04339.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T09:24:35Z","timestamp":1698744275000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2010.04339.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,21]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1365-2036.2010.04339.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04339.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,21]]}}}